Entero Healthcare Solutions Limited — Investor Meet, 04-06-2025: Analysts/Institutional Investor Meet/Con. Call Updates

Entero Healthcare Solutions reported Q4 revenue of Rs. 1,339 Cr, up 29% YoY, driven 11% organically and 22% from acquisitions, with gross margins improving to 9.8% and EBITDA rising 69% to Rs. 49 Cr (3.7% margin). FY25 revenue crossed Rs. 5,096 Cr (+30%), with PAT at Rs. 107 Cr (2.7x YoY). Management highlighted 95,300 retail pharmacies and 3,600 hospitals served, with 10 acquisitions adding Rs. 792 Cr annualized revenue. FY26 targets 30%+ growth, 4%+ EBITDA margins, and better working capital. Growth is expected at 1.5–2x industry levels, backed by margin-accretive acquisitions and tech-driven distribution.